
Saturday, September 14, 2024 5:42:57 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent HRMY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 12:30:15 PM
- Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 • Business Wire • 06/11/2025 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2025 08:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2025 12:30:13 PM
- Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation • Business Wire • 06/05/2025 12:05:00 PM
- Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference • Business Wire • 06/04/2025 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2025 08:18:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2025 08:07:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/09/2025 08:07:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2025 08:15:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2025 08:13:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2025 12:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 12:00:13 PM
- Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance • Business Wire • 05/06/2025 11:30:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/29/2025 06:47:40 PM
- Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025 • Business Wire • 04/29/2025 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2025 08:06:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2025 08:05:53 PM
- Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome • Business Wire • 04/08/2025 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/04/2025 09:52:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/04/2025 09:51:39 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/04/2025 08:20:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/04/2025 08:19:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/04/2025 08:17:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2025 12:15:14 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM